Respectfully , I think PR's do move SP but they don't maintain momentum.
A good PR will jump the SP but there has to be an underlying "promise" of tangible progress.
The test results are stellar but that has been something everyone is used to now.The SP spikes but drifts back down because people take profits and wait for the next PR and repeat the process.
Cox's write-ups help boost things but the status quo is that everyone is waiting for the "Big Bang" and that is comming.
Filing with the FDA will see a great deal of excitement but even that doesn't produce a marketed product.(Don't get me wrong , it will move things)
The SP will be greatly improved this year but the "Big Bang" will come when the FDA reacts favorably and investors start figuring market size and market share into the SP.
That could happen this year also but the fact is that investors have to be able to "quantify" value in order to invest in something.
Right now we're investing in strong belief and credentials,which is normal.But that doesn't translate to dollars until market size and market share are "fleshed-out".
Then the SP will mushroom. Kelt
News 
Market Data 
Discover 
AI
